Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Aligos Therapeutics, Inc. (ALGS) insider trading activity

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is > 10% Shareholder of Aligos Therapeutics, Inc.. Currently has a direct ownership of 1.91 Million shares of ALGS, which is worth approximately $39.7 Million. The most recent transaction as insider was on Oct 20, 2020, when has been sold 1,906,191 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.91M

0% 3M change

0% 12M change

Total Value Held $39.7 Million

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 20 2020	BUY Conversion of derivative security	-	1,906,191 Added 50.0%	1,906,191 Common Stock

Also insider at

VERV

Verve Therapeutics, Inc. Healthcare

> 10% Shareholder

NUVL

Nuvalent, Inc. Healthcare

> 10% Shareholder

EWTX

Edgewise Therapeutics, Inc. Healthcare

> 10% Shareholder

OLMA

Olema Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

RTVA

Artiva Biotherapeutics, Inc.

ACRV

Acrivon Therapeutics, Inc.

BOLD

Boundless Bio, Inc.

ZBIO

Zenas BioPharma, Inc.

> 10% Shareholder

WBI